+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurorehabilitation Devices Market - Global Forecast 2026-2032- Product Image
Neurorehabilitation Devices Market - Global Forecast 2026-2032- Product Image
Sale

Neurorehabilitation Devices Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674192
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurorehabilitation Devices Market is projected to reach USD 1.66 Billion in 2026. It is expected to continue growing at a CAGR of 7.98%, reaching USD 2.62 Billion by 2032.

The neurorehabilitation devices market is moving from equipment-centered therapy toward connected, measurable, and patient-specific rehabilitation. Demand is supported by a large and growing neurological disease burden: WHO-backed research published in The Lancet Neurology estimated that more than 3 billion people were living with a neurological condition in 2021, while WHO notes that the population aged 60 years and older is expected to reach 2.1 billion by 2050.

This creates sustained need for robotic rehabilitation systems, functional electrical stimulation devices, wearable gait and motion sensors, virtual reality therapy, neurostimulation platforms, and brain-computer interface-enabled solutions. Providers and payers are prioritizing technologies that improve therapy intensity, document functional outcomes, support remote patient monitoring, and extend rehabilitation beyond specialist centers for stroke, spinal cord injury, traumatic brain injury, Parkinson’s disease, multiple sclerosis, and cerebral palsy.

Transformative Shifts in Neurorehabilitation

The neurorehabilitation devices landscape is being reshaped by three connected shifts: decentralization of care, outcome-based procurement, and technology convergence. Rehabilitation is no longer limited to inpatient and outpatient clinics; home-based and hybrid neurorehabilitation models are expanding as wearable sensors, telerehabilitation platforms, and cloud dashboards enable supervised therapy at scale.

At the same time, hospitals and rehabilitation networks are seeking devices that generate objective evidence on gait, balance, range of motion, spasticity, upper-limb function, and therapy adherence. Robotics, virtual reality rehabilitation, functional electrical stimulation, non-invasive brain stimulation, digital therapeutics, and assistive technologies are increasingly integrated into multidisciplinary care pathways for stroke recovery, spinal cord injury rehabilitation, traumatic brain injury care, multiple sclerosis management, cerebral palsy therapy, and Parkinson’s disease rehabilitation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across neurorehabilitation devices by improving assessment, personalization, and workflow efficiency. AI-enabled motion analysis can help quantify impairment, detect compensatory movement, and monitor progress using data from wearables, cameras, robotic platforms, and connected therapy systems.

The most valuable AI applications are emerging where algorithms support clinicians rather than replace them. Adaptive rehabilitation robotics can adjust assistance levels, digital platforms can recommend therapy progression based on patient performance, and predictive analytics can identify adherence risks. Adoption depends on clinical validation, transparent model governance, cybersecurity, interoperability, and compliance with evolving medical device regulations for software-driven and connected rehabilitation technologies.

Key Regional Insights

Asia-Pacific is a high-potential region for neurorehabilitation devices as China, Japan, India, South Korea, Australia, and ASEAN countries invest in hospital modernization, aging-care infrastructure, digital health, and domestic medical technology capacity. Japan’s super-aged population, South Korea’s advanced robotics ecosystem, China’s expanding hospital infrastructure, and Australia’s structured rehabilitation pathways support adoption of rehabilitation robotics, wearable monitoring, virtual reality therapy, and connected neurorehabilitation platforms. India and Southeast Asian markets offer long-term access-driven opportunities as stroke services, neurology departments, and rehabilitation networks continue to develop.

North America remains a leading commercialization region due to strong rehabilitation networks, FDA-regulated device pathways, payer attention to functional outcomes, and active investment in digital health and connected care. Europe benefits from universal healthcare systems, rehabilitation research networks, clinical evidence standards, and MDR-driven quality expectations, with adoption supported by aging populations and established neurorehabilitation services. Latin America is improving access through private hospital groups, public neurology programs, and rising awareness of post-stroke rehabilitation, while the Middle East is investing in specialty rehabilitation centers, advanced hospitals, and medical tourism. Africa remains underpenetrated but has rising need for cost-effective, portable, durable, and training-light neurorehabilitation technologies that can address workforce and infrastructure constraints.

Key Group Insights

ASEAN markets are becoming more attractive as urban hospital systems expand neurorehabilitation capacity and governments emphasize noncommunicable disease management, stroke care, and digital health infrastructure. The GCC is prioritizing advanced rehabilitation hospitals, medical tourism, and technology-enabled care, creating opportunities for robotic rehabilitation systems, virtual reality therapy, remote monitoring platforms, and high-acuity neurorehabilitation equipment.

The European Union is important for evidence-led adoption, regulatory rigor, patient safety requirements, and cross-border research collaboration in neurorehabilitation devices. BRICS countries offer scale, local manufacturing potential, and rising neurological care demand, although reimbursement, specialist availability, and access to rehabilitation services vary widely. G7 markets remain central to premium device adoption, clinical validation, reimbursement innovation, and hospital-led digital transformation. NATO countries also show demand linked to trauma rehabilitation, veteran care, spinal cord injury treatment, brain injury recovery, and advanced assistive technologies for functional recovery.

Key Country Insights

The United States leads in neurorehabilitation device innovation, clinical trials, regulatory submissions, and commercialization, supported by advanced rehabilitation hospitals, academic medical centers, and a large stroke and brain injury care base. Canada emphasizes evidence-based adoption, connected care, and rehabilitation access across provincial healthcare systems. Mexico and Brazil are expanding private-sector rehabilitation access and neurology services, with Brazil representing the largest opportunity in Latin America due to its broad hospital base and high demand for post-stroke and neurodegenerative rehabilitation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging demographics with established neurorehabilitation services, national health systems, and growing interest in digital rehabilitation tools; Germany is especially strong in engineering-led rehabilitation technology and clinical adoption of advanced medical devices. Russia maintains demand across large neurology and rehabilitation networks but faces procurement complexity and regional access variation. In Asia-Pacific, China is scaling hospital investment and domestic medtech development, India offers long-term access-driven growth as rehabilitation capacity expands, Japan and South Korea support robotics, sensor-enabled therapy, and aging-care solutions, and Australia benefits from structured rehabilitation pathways, digital health readiness, and established clinical governance for assistive and therapeutic technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated neurorehabilitation solutions that reduce therapist burden, increase therapy dosage, and generate measurable functional outcomes. Product roadmaps should combine device performance with software analytics, secure data infrastructure, remote monitoring, patient engagement tools, and interoperability with electronic health records where feasible.

Commercial strategy should be localized by reimbursement maturity, care setting, workforce availability, and infrastructure readiness. Premium robotic rehabilitation systems may fit advanced hospitals and specialty centers, while portable functional electrical stimulation devices, sensor-based assessment tools, wearable monitoring, and telerehabilitation platforms may scale faster in access-constrained markets. Partnerships with rehabilitation networks, universities, payers, public health systems, and patient advocacy groups can accelerate clinical evidence generation, clinician training, and adoption.

Research Methodology

This executive summary is developed using a structured secondary-research methodology aligned with established industry research standards. Inputs include public health data from WHO and peer-reviewed neurological burden research, medical device regulatory references, clinical rehabilitation literature, product category analysis, reimbursement signals, demographic indicators, and regional healthcare infrastructure evidence.

Insights are triangulated across disease burden, aging trends, technology maturity, regulatory direction, procurement behavior, reimbursement readiness, and care-delivery models. The analysis focuses on verified, data-backed market drivers rather than speculative forecasts, with emphasis on practical implications for manufacturers, investors, providers, policymakers, and strategic decision-makers in neurorehabilitation devices.

Conclusion

Neurorehabilitation devices are becoming essential tools for addressing the global neurological disability burden. The market is supported by aging populations, rising prevalence of stroke and neurodegenerative conditions, workforce constraints in therapy, and demand for objective, data-driven rehabilitation outcomes.

Future leadership will depend on clinical proof, usability, affordability, AI governance, cybersecurity, interoperability, and the ability to integrate devices into real care pathways across hospitals, outpatient centers, and home-based rehabilitation. Organizations that combine therapeutic efficacy with scalable digital infrastructure and region-specific commercialization models will be best positioned to support long-term growth in neurorehabilitation devices.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurorehabilitation Devices Market, by Device Type
7.1. Introduction
7.2. Biofeedback System
7.2.1. EMG Biofeedback
7.2.2. Pressure Biofeedback
7.3. Exoskeleton
7.3.1. Lower Limb
7.3.2. Upper Limb
7.4. Functional Electrical Stimulation Device
7.4.1. Implantable
7.4.2. Surface
7.5. Neuromodulation Device
7.5.1. Invasive
7.5.2. Noninvasive
7.6. Virtual Reality System
8. Neurorehabilitation Devices Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatric
9. Neurorehabilitation Devices Market, by Application
9.1. Introduction
9.2. Cerebral Palsy
9.2.1. Ataxic
9.2.2. Dyskinetic
9.2.3. Spastic
9.3. Multiple Sclerosis
9.3.1. Progressive
9.3.2. Relapsing Remitting
9.4. Parkinson's Disease
9.4.1. Advanced Stage
9.4.2. Early Stage
9.5. Spinal Cord Injury
9.6. Stroke
9.6.1. Hemorrhagic
9.6.2. Ischemic
10. Neurorehabilitation Devices Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
10.5. Rehabilitation Centers
10.6. Research Institutes
11. Neurorehabilitation Devices Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Neurorehabilitation Devices Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Neurorehabilitation Devices Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. ANT Neuro B.V.
15.3. Bioness, Inc.
15.4. BioXtreme Robotics Rehabilitation
15.5. Boston Scientific Corporation
15.6. BTS Bioengineering S.p.A.
15.7. Cyberdyne Inc.
15.8. Ekso Bionics Holdings, Inc.
15.9. Hasomed GmbH
15.10. Hocoma AG
15.11. Kinova Inc.
15.12. Medtronic plc
15.13. Myomo, Inc.
15.14. NeuroStyle Pte Ltd
15.15. ReWalk Robotics Ltd.
15.16. Tyromotion GmbH
15.17. Vibrant Ltd.
16. Key Experts
List of Figures
FIGURE 1. Global Neurorehabilitation Devices Market, Years Considered for the Study
FIGURE 2. Global Neurorehabilitation Devices Market, Research Design
FIGURE 3. Global Neurorehabilitation Devices Market, Research Framework
FIGURE 4. Global Neurorehabilitation Devices Market, Data Triangulation
FIGURE 5. Global Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Neurorehabilitation Devices Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 7. Global Neurorehabilitation Devices Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Neurorehabilitation Devices Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Neurorehabilitation Devices Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Neurorehabilitation Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Neurorehabilitation Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Neurorehabilitation Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Neurorehabilitation Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Neurorehabilitation Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Neurorehabilitation Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Neurorehabilitation Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Neurorehabilitation Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Neurorehabilitation Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Neurorehabilitation Devices Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Neurorehabilitation Devices Market Segmentation & Coverage
TABLE 2. Global Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 4. Global Biofeedback System Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Biofeedback System Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Biofeedback System Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global EMG Biofeedback Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global EMG Biofeedback Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global EMG Biofeedback Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Pressure Biofeedback Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Pressure Biofeedback Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Pressure Biofeedback Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Exoskeleton Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Exoskeleton Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Exoskeleton Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Lower Limb Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Lower Limb Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Lower Limb Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Upper Limb Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Upper Limb Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Upper Limb Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Functional Electrical Stimulation Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Functional Electrical Stimulation Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Functional Electrical Stimulation Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Implantable Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Implantable Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Implantable Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Surface Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Surface Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Surface Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Neuromodulation Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Neuromodulation Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Neuromodulation Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Invasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Invasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Invasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Noninvasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Noninvasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Noninvasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Virtual Reality System Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Virtual Reality System Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Virtual Reality System Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 44. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Cerebral Palsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cerebral Palsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cerebral Palsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Ataxic Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Ataxic Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Ataxic Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Dyskinetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Dyskinetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Dyskinetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Spastic Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Spastic Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Spastic Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Progressive Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Progressive Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Progressive Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Relapsing Remitting Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Relapsing Remitting Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Relapsing Remitting Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Parkinson's Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Parkinson's Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Parkinson's Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Advanced Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Advanced Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Advanced Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Spinal Cord Injury Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Spinal Cord Injury Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Spinal Cord Injury Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Stroke Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Stroke Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Stroke Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hemorrhagic Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hemorrhagic Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hemorrhagic Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Ischemic Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Ischemic Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Ischemic Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Rehabilitation Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Rehabilitation Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Rehabilitation Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. North America Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. North America Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 128. North America Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 129. North America Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 130. North America Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 131. North America Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 132. North America Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 133. North America Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. North America Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 135. North America Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 136. North America Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 137. North America Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 138. North America Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Latin America Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Latin America Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 141. Latin America Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 142. Latin America Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 143. Latin America Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 144. Latin America Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 145. Latin America Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 146. Latin America Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Latin America Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 148. Latin America Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 149. Latin America Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 150. Latin America Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 151. Latin America Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Europe Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Europe Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 154. Europe Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 155. Europe Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 156. Europe Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 157. Europe Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 158. Europe Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 159. Europe Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Europe Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 161. Europe Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 162. Europe Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 163. Europe Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 164. Europe Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Middle East Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Middle East Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 167. Middle East Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 168. Middle East Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 169. Middle East Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 170. Middle East Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 171. Middle East Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 172. Middle East Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Middle East Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 174. Middle East Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 175. Middle East Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 176. Middle East Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 177. Middle East Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Africa Neurorehabilitation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Africa Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 180. Africa Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 181. Africa Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 182. Africa Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 183. Africa Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 184. Africa Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 185. Africa Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Africa Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 187. Africa Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 188. Africa Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 189. Africa Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 190. Africa Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Global Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. ASEAN Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. ASEAN Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 194. ASEAN Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 195. ASEAN Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 196. ASEAN Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 197. ASEAN Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 198. ASEAN Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 199. ASEAN Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. ASEAN Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 201. ASEAN Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 202. ASEAN Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 203. ASEAN Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 204. ASEAN Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. GCC Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. GCC Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 207. GCC Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 208. GCC Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 209. GCC Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 210. GCC Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 211. GCC Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 212. GCC Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. GCC Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 214. GCC Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 215. GCC Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 216. GCC Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 217. GCC Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. European Union Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. European Union Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 220. European Union Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 221. European Union Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 222. European Union Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 223. European Union Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 224. European Union Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 225. European Union Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. European Union Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 227. European Union Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 228. European Union Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 229. European Union Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 230. European Union Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. BRICS Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. BRICS Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 233. BRICS Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 234. BRICS Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 235. BRICS Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 236. BRICS Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 237. BRICS Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 238. BRICS Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. BRICS Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 240. BRICS Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 241. BRICS Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 242. BRICS Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 243. BRICS Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. G7 Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. G7 Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 246. G7 Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 247. G7 Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 248. G7 Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 249. G7 Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 250. G7 Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 251. G7 Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. G7 Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 253. G7 Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 254. G7 Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 255. G7 Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 256. G7 Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. NATO Neurorehabilitation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. NATO Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 259. NATO Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 260. NATO Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 261. NATO Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 262. NATO Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 263. NATO Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 264. NATO Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. NATO Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 266. NATO Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 267. NATO Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 268. NATO Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 269. NATO Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Global Neurorehabilitation Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 271. United States Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 272. United States Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 273. United States Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 274. United States Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 275. United States Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 276. United States Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 277. United States Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 278. United States Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. United States Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 280. United States Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 281. United States Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 282. United States Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 283. United States Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Canada Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 285. Canada Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 286. Canada Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 287. Canada Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 288. Canada Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 289. Canada Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 290. Canada Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 291. Canada Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Canada Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 293. Canada Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 294. Canada Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 295. Canada Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 296. Canada Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Mexico Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 298. Mexico Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 299. Mexico Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 300. Mexico Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 301. Mexico Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 302. Mexico Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 303. Mexico Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 304. Mexico Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. Mexico Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 306. Mexico Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 307. Mexico Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 308. Mexico Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 309. Mexico Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Brazil Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 311. Brazil Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 312. Brazil Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 313. Brazil Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 314. Brazil Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 315. Brazil Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 316. Brazil Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 317. Brazil Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. Brazil Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 319. Brazil Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 320. Brazil Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 321. Brazil Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 322. Brazil Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. United Kingdom Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 324. United Kingdom Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 325. United Kingdom Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 326. United Kingdom Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 327. United Kingdom Neurorehabilitation Devices Market Size, by Functional Electrical Stimulation Device, 2017-2032 (USD Million)
TABLE 328. United Kingdom Neurorehabilitation Devices Market Size, by Neuromodulation Device, 2017-2032 (USD Million)
TABLE 329. United Kingdom Neurorehabilitation Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 330. United Kingdom Neurorehabilitation Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. United Kingdom Neurorehabilitation Devices Market Size, by Cerebral Palsy, 2017-2032 (USD Million)
TABLE 332. United Kingdom Neurorehabilitation Devices Market Size, by Multiple Sclerosis, 2017-2032 (USD Million)
TABLE 333. United Kingdom Neurorehabilitation Devices Market Size, by Parkinson's Disease, 2017-2032 (USD Million)
TABLE 334. United Kingdom Neurorehabilitation Devices Market Size, by Stroke, 2017-2032 (USD Million)
TABLE 335. United Kingdom Neurorehabilitation Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Germany Neurorehabilitation Devices Market Size, 2017-2032 (USD Million)
TABLE 337. Germany Neurorehabilitation Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 338. Germany Neurorehabilitation Devices Market Size, by Biofeedback System, 2017-2032 (USD Million)
TABLE 339. Germany Neurorehabilitation Devices Market Size, by Exoskeleton, 2017-2032 (USD Million)
TABLE 340. Germany Neurorehabilitation Devices Market Size, by Func

Companies Mentioned

  • Abbott Laboratories
  • ANT Neuro B.V.
  • Bioness, Inc.
  • BioXtreme Robotics Rehabilitation
  • Boston Scientific Corporation
  • BTS Bioengineering S.p.A.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Hasomed GmbH
  • Hocoma AG
  • Kinova Inc.
  • Medtronic plc
  • Myomo, Inc.
  • NeuroStyle Pte Ltd
  • ReWalk Robotics Ltd.
  • Tyromotion GmbH
  • Vibrant Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.66 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.62 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Neurorehabilitation Market - Forecast from 2026 to 2031 - Product Image

Neurorehabilitation Market - Forecast from 2026 to 2031

  • Report
  • 151 Pages
  • Global
From
Neurorehabilitation Devices - Global Strategic Business Report - Product Image

Neurorehabilitation Devices - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
Medical Neurorehabilitation Management Software Market - Global Forecast 2026-2032 - Product Image

Medical Neurorehabilitation Management Software Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Neurorehabilitation Devices Market Report 2026 - Product Image

Neurorehabilitation Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2026-2034 - Product Image

Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From

About the Neurorehabilitation Market

Neurorehabilitation is a field of medicine that focuses on restoring neurological function after injury or illness. It is a rapidly growing area of neurology, with a range of devices and technologies being developed to help patients recover from neurological conditions. Neurorehabilitation devices are designed to improve motor, sensory, and cognitive functions, as well as to reduce pain and improve quality of life. These devices can range from simple tools such as exercise balls and hand weights, to more complex technologies such as robotic exoskeletons and virtual reality systems. Neurorehabilitation devices are used to help patients with a variety of neurological conditions, including stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, and Parkinson's disease. They can also be used to help patients with cognitive impairments, such as dementia and Alzheimer's disease. Some of the companies in the Neurorehabilitation market include Bioness, Ekso Bionics, Hocoma, ReWalk Robotics, and Neurolutions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.